ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

Bladder Carcinoma · Ureter Carcinoma · Renal Pelvis Carcinoma · Non-small Cell Lung Cancer · Invasive Breast Carcinoma · Cutaneous Melanoma · Esophageal Carcinoma · Gastroesophageal Junction Carcinoma · Gastric Adenocarcinoma · Pancreatic Adenocarcinoma · Squamous Cell Carcinoma of the Head and Neck · Epithelial Ovarian Carcinoma · Fallopian Tube Carcinoma · Endometrial Carcinoma · Renal Cell Carcinoma · Rectal Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Susan Binkley)
  • Ironwood Cancer & Research Centers, Chandler, Arizona, United States

    Contact: Study coordinator (Sarah Shilling)
  • Genesis Cancer Center, Hot Springs, Arkansas, United States

  • University of California, San Diego, La Jolla, California, United States

    Contact: Study coordinator (Susanna Lee)
  • Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

    Contact: Study coordinator (Alexandra Clark)
  • Redwood City, Redwood City, California, United States

    Contact: Study coordinator (Clinical Trial Operations)
  • Sutter Institute for Medical Research, Sacramento, California, United States

  • University of Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Emily Harper)
  • Memorial Healthcare System, Hollywood, Florida, United States

    Contact: Study coordinator (Machelle Seymour)
  • The Oncology Institute of Hope & Innovation, Lakeland, Florida, United States

    Contact: Study coordinator (Shanna Kennedy)
  • Tulane Cancer Center, New Orleans, Louisiana, United States

    Contact: Study coordinator (Alex Lieberman)
  • Christus Highland/ Boniol, Shreveport, Louisiana, United States

    Contact: Study coordinator (Nancy Hassan)
  • Central Maine Medical Center, Lewiston, Maine, United States

    Contact: Study coordinator (Jessica Bolduc)
  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Angela Newman)
  • Mayo Clinic (Rochester), Rochester, Minnesota, United States

    Contact: Study coordinator (Renee Bradshaw)
  • Astera Cancer Care, East Brunswick, New Jersey, United States

    Contact: Study coordinator (Percy Yeung)
  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • UNC- Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Chris Hilliiard)
  • The Christ Hospital Cancer Center, Cincinnati, Ohio, United States

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Maria Clark)
  • Toledo Clinic Cancer Center, Toledo, Ohio, United States

    Contact: Study coordinator (Jennifer Martinez)
  • Crozer-Keystone Health System, Broomall, Pennsylvania, United States

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Willdragon Wang)
  • Cancer Care Associates of York, York, Pennsylvania, United States

    Contact: Study coordinator (Katelyn Bean)
  • Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Angela Buffkin)
  • Carolina Blood and Cancer Care Associates, Rock Hill, South Carolina, United States

    Contact: Study coordinator (Carson Lee Gallo)
  • UT Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Saketh Nadimpalli)
  • DHR Health Advance Care Center, Edinburg, Texas, United States

    Contact: Study coordinator (Edgar Lopez Pacheco)
  • The Center for Cancer and Blood Disorders, Forth Worth, Texas, United States

    Contact: Study coordinator (Anna Rose Abangan)
  • The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (James Denno)
  • Utah Cancer Specialists, Salt Lake City, Utah, United States

    Contact: Study coordinator (Angela Nuttall)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Rachel Luedtke)
  • CHU Besançon, Besançon, France

    Contact: Study coordinator (Christine Guglielmetti-Bargot)
  • Hôpital Franco-Britannique, Levallois-Perret, France

    Contact: Study coordinator (Hajar Eddahbi)
  • Institut Paoli-Calmettes, Marseille, France

    Contact: Study coordinator (Sameh Bou Ali)
  • Ambroise Paré-Hartmann, Neuilly, France

    Contact: Study coordinator (Messaouda Merzoug)
  • APHP Tenon Hospital - Sorbonne, Paris, France

    Contact: Study coordinator (Hakima Manseur)
  • Asklepios Klinik Altona, Hamburg, Germany

    Contact: Study coordinator (Dirk Arnold)
  • SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany

    Contact: Study coordinator (Josef Huber)
  • Ludwig Maximilian University Munich, Munich, Germany

    Contact: Study coordinator (C. Benedikt Westphalen)
  • Instituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS IRST, SrL, Meldola, Italy

    Contact: Study coordinator (Emanuela Montanari)
  • Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

    Contact: Study coordinator (Erika Gervasi)
  • Policlinico Universitario Agostino Gemelli, Roma, Italy

    Contact: Study coordinator (Ilenia Marino)
  • Hospital Teresa Herrera (C.H.U.A.C), A Coruña, Spain

    Contact: Study coordinator (Sabela Varela Rodriguez)
  • Vall Hebron Institute of Oncology, Barcelona, Spain

    Contact: Study coordinator (Pol Sisó Camarasa)
  • Hospital Clinic of Barcelona, Barcelona, Spain

    Contact: Study coordinator (Debora Moreno Fernandez)
  • ICO Institut Catala d'Oncologia, Barcelona, Spain

    Contact: Study coordinator (Ana Rosa Garcia Oliva)
  • Instituto Catalan de Oncologia de Girona, Girona, Spain

    Contact: Study coordinator (Begona Martin)
  • Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain

    Contact: Study coordinator (Sara Suárez Guerra)
  • Hospital San Carlos, Madrid, Spain

    Contact: Study coordinator (Raquel Rodriguez)
  • Hospital Universitario La Paz, Madrid, Spain

    Contact: Study coordinator (Claudia Morrugares Portero)
  • CIOSS HM Sanchinarro, Madrid, Spain

    Contact: Study coordinator (Begoña Martinez Montesino)
  • Hospital Universitario Virgen de la Victoria, Málaga, Spain

    Contact: Study coordinator (Juan Manuel Escandell)
  • CCS Hospital Universitari Parc Taulí, Sabadell, Spain

    Contact: Study coordinator (Jose Garcia Ruiz)
  • Hospital Clinico de Santiago de Compostela, Santiago de Compostela, Spain

    Contact: Study coordinator (Iria Portos)
  • Hospital Clínico de Valencia, Valencia, Spain

    Contact: Study coordinator (Matteo Stocco)
מובילי המחקר
  • Study Director

    Guardant Health, Inc.